Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Apr 25, 2022 10:15am
91 Views
Post# 34628686

RE:RE:RE:RE:RE:To clarify ...

RE:RE:RE:RE:RE:To clarify ...
Chianchin wrote: Raising money with a PP to leave that cash mostly idlle, than over pay GBT and afterwords stiff investors for using that money for a buy back is the worst coporate action any company can take. Bay street has a very very long unforgiven memory on that 


Don't think you'll have to worry about Bay Street or Wall Street.

When they come to the party it will be a whole new group of investors who are looking for the next level of operational success.

To this point - it's been 270 diehard builders (and a few thousand regular average joes who joined the builders) who are absolutely sold on building it better ... better - stronger - faster ... because we have the technology.  Oh wait ... that's something else ... but still applies.

This next phase is a different investor base and it takes time for them to show up.  They are a more conservative group and they are looking for regular operational growth.  That's what Samira is to develop next.

Sorry if you don't like it - just the way it is.




<< Previous
Bullboard Posts
Next >>